Meglitinides are a class of oral antidiabetic drugs that stimulate insulin release by closing ATP-dependent potassium channels in pancreatic beta cells. They are taken to improve blood sugar control in type 2 diabetes, typically before meals. The term combines the root meds declaring a pharmacological action with the -inide suffix common to similar drug classes.
Full pronunciation guide
